Literature DB >> 23958464

miR-128 and its target genes in tumorigenesis and metastasis.

Molin Li1, Weiming Fu, Lulu Wo, Xiaohong Shu, Fang Liu, Chuangang Li.   

Abstract

MicroRNAs (miRNAs) are a class of endogenous, non-coding, 18-24 nucleotide length single-strand RNAs that could modulate gene expression at post-transcriptional level. Previous studies have shown that miR-128 enriched in the brain plays an important role in the development of nervous system and the maintenance of normal physical functions. Aberrant expression of miR-128 has been detected in many types of human tumors and its validated target genes are involved in cancer-related biological processes such as cell proliferation, differentiation and apoptosis. In this review, we will summarize the roles of miR-128 and its target genes in tumorigenesis and metastasis.
Copyright © 2013 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Metastasis; MicroRNA-128 (miR-128); Target genes; Tumorigenesis

Mesh:

Substances:

Year:  2013        PMID: 23958464     DOI: 10.1016/j.yexcr.2013.07.031

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  41 in total

1.  Multiple functional linear model for association analysis of RNA-seq with imaging.

Authors:  Junhai Jiang; Nan Lin; Shicheng Guo; Jinyun Chen; Momiao Xiong
Journal:  Quant Biol       Date:  2015-08-15

2.  miR-128 regulates the apoptosis and proliferation of glioma cells by targeting RhoE.

Authors:  Chao Shang; Yang Hong; Yan Guo; Yun-Hui Liu; Yi-Xue Xue
Journal:  Oncol Lett       Date:  2015-11-17       Impact factor: 2.967

3.  MicroRNA-218 inhibits gastrointestinal stromal tumor cell and invasion by targeting KIT.

Authors:  Rong Fan; Jie Zhong; Sichang Zheng; Zhengting Wang; Ying Xu; Shuyi Li; Jie Zhou; Fei Yuan
Journal:  Tumour Biol       Date:  2013-12-29

4.  microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.

Authors:  Zhe Liu; Ruixia Du; Jin Long; Kejian Guo; Chunlin Ge; Shulong Bi; Yuanhong Xu
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

Review 5.  Role of MicroRNA Regulation in Obesity-Associated Breast Cancer: Nutritional Perspectives.

Authors:  Ravi Kasiappan; Dheeran Rajarajan
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

6.  Regulatory mechanism of microRNA-128 in osteosarcoma tumorigenesis and evolution through targeting SASH1.

Authors:  Zi Li; Jiangdong Ni; Deye Song; Muliang Ding
Journal:  Oncol Lett       Date:  2018-03-30       Impact factor: 2.967

7.  ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in Cancer.

Authors:  Marco Napoli; Avinashnarayan Venkatanarayan; Payal Raulji; Brooke A Meyers; William Norton; Lingegowda S Mangala; Anil K Sood; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Harina Vin; Madeleine Duvic; Michael B Tetzlaff; Jonathan L Curry; Alain H Rook; Hussein A Abbas; Cristian Coarfa; Preethi H Gunaratne; Kenneth Y Tsai; Elsa R Flores
Journal:  Cancer Cell       Date:  2016-06-13       Impact factor: 31.743

8.  Downregulation of MicroRNA eca-mir-128 in Seminal Exosomes and Enhanced Expression of CXCL16 in the Stallion Reproductive Tract Are Associated with Long-Term Persistence of Equine Arteritis Virus.

Authors:  Mariano Carossino; Pouya Dini; Theodore S Kalbfleisch; Alan T Loynachan; Igor F Canisso; Kathleen M Shuck; Peter J Timoney; R Frank Cook; Udeni B R Balasuriya
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

9.  microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.

Authors:  Zhe Liu; Yuanhong Xu; Jin Long; Kejian Guo; Chunlin Ge; Ruixia Du
Journal:  Chin J Cancer Res       Date:  2015-06       Impact factor: 5.087

10.  MiR-128b is down-regulated in gastric cancer and negatively regulates tumour cell viability by targeting PDK1/Akt/NF-κB axis.

Authors:  Ling Zhang; Jun Lei; Zi-Ling Fang; Jian-Ping Xiong
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.